Daily but not pulse calcitriol therapy improves growth in experimental uremia

Pediatric Nephrology

Volumn 14, Issue 7, 2000, Pages 658-663

  Mehls, Otto ^a   Knöller, Nora ^a   Oh, Jun ^a   Wesch, Horst ^b   Wünsche, Bernd ^c   Schmitt, Claus P ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c NONE

Author keywords

Intermittent calcitriol; Length gain; Total body calcium; Uremia

Indexed keywords

CALCITRIOL; CALCIUM; HUMAN GROWTH HORMONE; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BODY GROWTH; BODY WEIGHT; BONE METABOLISM; BONE MINERALIZATION; CONFERENCE PAPER; CONTROLLED STUDY; DIET; FEMALE; GROWTH RETARDATION; NEUTRON ACTIVATION ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SECONDARY HYPERPARATHYROIDISM; UREMIA;

EID: 0343293805     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670000346     Document Type: Conference Paper

References (28)

1. Dent CE, Harper C, Philpot OR (1961) The treatment of renalglomerular osteodystrophy. QJM 30:1-4
2. Royer PH, Mathieu H, Gerbeaux S (1962) Explorations biologiques du métabolisme calcique chez l'enfant. In: Rein et foie. Maladies de la Nutrition. Vittel: Symposium International sur la Lithiase Calcique
3. Potter D, Larsen D, Leumann E, Perin D, Simmons J, Piel CF, Holliday MA (1970) Treatment of chronic uremia in childhood. II. Hemodialysis. Pediatrics 46:678-689
4. Mehls O, Ritz E, Gilli G, Wangdak T, Krempien B (1978) Effect of vitamin D on growth in experimental uremia. Am J Clin Nutr 31:1927-1931
5. Mehls O, Ritz E (1983) Skeletal growth in experimental uremia. Kidney Int [Suppl] 15:S53-S62
6. Mehls O, Salusky IB (1987) Recent advances and controversies in childhood renal osteodystrophy. Pediatr Nephrol 1:212-223
7. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ (1984) Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 74:2136-2143
8. Brancaccio D, Gallieni M (1994) Recent advances in intravenous calcitriol treatment. Curr Opin Nephrol Hypertens 3:411-416
9. Dahl NV, Foote EF (1997) Pulse dose oral calcitriol therapy for renal osteodystrophy: literature review and practice recommendations. ANNA J 24:550-555
10. Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160-1166
11. Mucsi I, Hercz G (1997) Adynamic bone disease: pathogenesis, diagnosis and clinical relevance. Curr Opin Nephrol Hypertens 6:356-361
12. Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, Gales B, Salusky IB (1998) Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 53:205-211
13. Kovacs G, Fine RN, Worgall S, Schaefer F, Hunziker EB, Skottner-Lindun A, Mehls O (1991) Growth hormone prevents steroid-induced growth depression in health and uremia. Kidney Int 40:1032-1040
14. Velde JT, Burkhardt R, Kleiverda K, Leenheers-Binnendijk L, Sommerfeld W (1977) Methyl-meth-acrylate as an embedding medium in histopathology. Histopathology 1:319-330
15. Merz WA, Schenk RK (1970) Quantitative structural analysis of human cancellous bone. Acta Anat (Basel) 75:54-66
16. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
17. Park EA (1939) Observation on the pathology of rickets with particular reference to the changes at the cartilage shaft junctions of the growing bones. Harvey lectures. Williams and Wilkins, Baltimore, p 157
18. Klaus G, Meinhold-Heerlein R, Milde P, Ritz E, Mehls O (1991) Effect of vitamin D on growth cartilage cell proliferation in vitro. Pediatr Nephrol 5:461-466
19. Szabo A, Merke J, Beier E, Mall G, Ritz E (1989) 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 35:1049-1056
20. Nagakura K, Abe E, Suda T, Hayakawa M, Nakamura H, Tazaki H (1986) Inhibitory effect of 1 alpha,25-dihydroxyvitamin D3 on the growth of the renal carcinoma cell line. Kidney Int 29: 834-840
21. Weih M, Orth S, Weinreich T, Reichel H, Ritz E (1994) Inhibition of growth by calcitriol in a proximal tubular cell line (OK). Nephrol Dial Transplant 9:1390-1394
22. Matthias S, Busch R, Merke J, Mall G, Thomasset M, Ritz E (1991) Effects of 1,25(OH)2D3 on compensatory renal growth in the growing rat. Kidney Int 40:212-218
23. Van de Kerkhof PC (1998) An update on vitamin D3 analogues in the treatment of psoriasis. Skin Pharmacol Appl Skin Physiol 11:2-10
24. Klaus G, Merke J, Eing H, Hugel U, Milde P, Reichel H, Ritz E, Mehls O (1991) 1,25(OH)2D3 receptor regulation and 1,25(OH)2D3 effects in primary cultures of growth cartilage cells of the rat. Calcif Tissue Int 49: 340-348
25. Klaus G, Weber L, Rodriguez J, Fernandez P, Klein T, Grulich-Henn J, Hugel U, Ritz E, Mehls O (1998) Interaction of IGF-I and 1 alpha, 25(OH)2D3 on receptor expression and growth stimulation in rat growth plate chondrocytes. Kidney Int 53:1152-1161
26. Ardissino G, Schmitt CP, Bianchi ML, Daccò V, Claris-Appiani A, Mehls O, for the European Study Group on Vitamin D in Children with Renal Failure (2000) No difference in intestinal strontium absorption after oral or iv calcitriol bolus in children with CRF and secondary hyperparathyroidism. Kidney Int (in press)
27. Sanchez CP, Salusky IB, Kuizon BD, Abdella P, Juppner H, Goodman WG (1998) Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int 54:1879-1887
28. Herrmann P, Ritz E, Schmidt-Gayk H, Schafer I, Geyer J, Nonnast-Daniel B, Koch KM, Weber U, Horl W, Haas-Worle A (1994) Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: a randomised prospective trial. Nephron 67:48-53